Efficacy of Oral Ginger (Zingiber officinale) for Dysmenorrhea: A Systematic Review and Meta-Analysis.
Chen Xiao ChenBruce BarrettKristine L KwekkeboomPublished in: Evidence-based complementary and alternative medicine : eCAM (2016)
This systematic review examines the efficacy of oral ginger for dysmenorrhea. Key biomedical databases and grey literature were searched. We included randomized controlled trials comparing oral ginger against placebo or active treatment in women with dysmenorrhea. Six trials were identified. Two authors independently reviewed the articles, extracted data, and assessed risk of bias. Discrepancies were resolved by consensus with a third reviewer. We completed a narrative synthesis of all six studies and exploratory meta-analyses of three studies comparing ginger with placebo and two studies comparing ginger with a nonsteroidal anti-inflammatory drug (NSAID). Ginger appeared more effective for reducing pain severity than placebo. The weighted mean difference on a 10 cm visual analogue scale was 1.55 cm (favoring ginger) (95% CI 0.68 to 2.43). No significant difference was found between ginger and mefenamic acid (an NSAID). The standardized mean difference was 0 (95% CI -0.40 to 0.41). Available data suggest that oral ginger could be an effective treatment for menstrual pain in dysmenorrhea. Findings, however, need to be interpreted with caution because of the small number of studies, poor methodological quality of the studies, and high heterogeneity across trials. The review highlights the need for future trials with high methodological quality.
Keyphrases
- systematic review
- meta analyses
- case control
- randomized controlled trial
- chronic pain
- electronic health record
- big data
- magnetic resonance
- anti inflammatory
- pain management
- computed tomography
- quality improvement
- emergency department
- clinical trial
- neuropathic pain
- double blind
- spinal cord injury
- spinal cord
- current status
- clinical practice
- deep learning
- study protocol
- postoperative pain
- adverse drug